Targeted Inhibition of Angiogenic Factors in AIDS-related Disorders

E-ISSN： 1875-5852|3|2|115-128

ISSN： 1568-0053

Source： Current Drug Targets - Infectious Disorders, Vol.3, Iss.2, 2003-06, pp. : 115-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

`Serostim' effective against AIDS-related metabolic disorders

Inpharma, Vol. 1, Iss. 1355, 2002-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Treatment options of AIDS-related lymphoma

By Schmidt-Wolf Ingo GH Rockstroh Jürgen K Schlegel Uwe Pels Hendrik Mey Ulrich Strehl John Weiss Rudolf Huhn Dieter

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 8, 2003-08 ,pp. : 1331-1343

Informa Healthcare

Access to resources Recommend Favorite

Mechanisms of AIDS-related lymphoma pathogenesis

By Huysentruyt Leanne C McGrath Michael S

Future Virology, Vol. 7, Iss. 3, 2012-03 ,pp. : 229-238

Future Medicine

Access to resources Recommend Favorite

Somatropin streets ahead for AIDS-related wasting

Inpharma, Vol. 1, Iss. 1257, 2000-01 ,pp. : 8-9

Adis International

Access to resources Recommend Favorite

Filgrastim beneficial in AIDS-related CMV retinitis

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 364, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite